The stock of Nutex Health Inc (NASDAQ: NUTX) has decreased by -10.81 when compared to last closing price of 22.42.Despite this, the company has seen a loss of -20.16% in its stock price over the last five trading days. prnewswire.com reported 2024-08-26 that Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho, Aug. 26, 2024 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post Falls, Idaho.
Is It Worth Investing in Nutex Health Inc (NASDAQ: NUTX) Right Now?
Company’s 36-month beta value is 0.09.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NUTX is 2.90M, and currently, short sellers hold a 4.38% ratio of that floaft. The average trading volume of NUTX on September 25, 2024 was 69.21K shares.
NUTX’s Market Performance
NUTX stock saw a decrease of -20.16% in the past week, with a monthly decline of -7.54% and a quarterly a decrease of 252.11%. The volatility ratio for the week is 10.35%, and the volatility levels for the last 30 days are 11.18% for Nutex Health Inc (NUTX). The simple moving average for the past 20 days is -13.04% for NUTX’s stock, with a 33.98% simple moving average for the past 200 days.
Analysts’ Opinion of NUTX
Many brokerage firms have already submitted their reports for NUTX stocks, with Maxim Group repeating the rating for NUTX by listing it as a “Buy.” The predicted price for NUTX in the upcoming period, according to Maxim Group is $45 based on the research report published on September 18, 2024 of the current year 2024.
Northland Capital, on the other hand, stated in their research note that they expect to see NUTX reach a price target of $3. The rating they have provided for NUTX stocks is “Outperform” according to the report published on February 22nd, 2023.
NUTX Trading at 28.38% from the 50-Day Moving Average
After a stumble in the market that brought NUTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.56% of loss for the given period.
Volatility was left at 11.18%, however, over the last 30 days, the volatility rate increased by 10.35%, as shares sank -17.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +236.13% upper at present.
During the last 5 trading sessions, NUTX fell by -20.16%, which changed the moving average for the period of 200-days by -33.23% in comparison to the 20-day moving average, which settled at $22.79. In addition, Nutex Health Inc saw -25.93% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUTX starting from Bates Jon Christian, who purchase 1,350 shares at the price of $21.46 back on Aug 22 ’24. After this action, Bates Jon Christian now owns 2,277 shares of Nutex Health Inc, valued at $28,970 using the latest closing price.
DeTillio Joshua, the Chief Operating Officer of Nutex Health Inc, purchase 1,300 shares at $17.85 during a trade that took place back on Aug 19 ’24, which means that DeTillio Joshua is holding 4,233 shares at $23,205 based on the most recent closing price.
Stock Fundamentals for NUTX
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.19 for the gross margin
The net margin for Nutex Health Inc stands at -0.14. The total capital return value is set at 0.05. Equity return is now at value -48.78, with -8.83 for asset returns.
Based on Nutex Health Inc (NUTX), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.35. The debt to equity ratio resting at 0.75. The interest coverage ratio of the stock is 0.94.
Currently, EBITDA for the company is 16.3 million with net debt to EBITDA at 7.11. When we switch over and look at the enterprise to sales, we see a ratio of 1.27. The receivables turnover for the company is 4.23for trailing twelve months and the total asset turnover is 0.65. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.59.
Conclusion
In a nutshell, Nutex Health Inc (NUTX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
